New Horizons for Personalised Treatment in Gastroesophageal Cancer
Gastric and gastroesophageal junction adenocarcinoma (GEA) is still responsible for a huge health burden worldwide, being the second most common cause of cancer-related death globally [...]
Main Authors: | Massimiliano Salati, Andrea Spallanzani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/2/311 |
Similar Items
-
Special Issue: Present and Future of Personalised Medicine for Endocrine Cancers
by: Cristina L. Ronchi, et al.
Published: (2022-04-01) -
A New Horizon for Atopic Dermatitis Treatments: JAK Inhibitors
by: Mircea Tampa, et al.
Published: (2023-02-01) -
Unveiling New Horizons: Progress in the Management of Gastrointestinal and Hepatobiliary Cancer
by: Christian Sebesta, et al.
Published: (2023-09-01) -
Feature Review Papers on Gastroesophageal Junction and Gastric Cancers
by: Caroline Gronnier
Published: (2022-08-01) -
Personality, Intervention and Psychological Treatment: Untangling and Explaining New Horizons and Perspectives
by: Casandra I. Montoro, et al.
Published: (2022-07-01)